- Trials with a EudraCT protocol (276)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
276 result(s) found for: Myocardial revascularization.
Displaying page 1 of 14.
EudraCT Number: 2014-005569-58 | Sponsor Protocol Number: BAY59-7939/17454 | Start Date*: 2015-09-23 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: An international, multicenter, randomized, double-blind, placebo-controlled phase 3 trial investigating the efficacy and safety of Rivaroxaban to reduce the risk of major thrombotic vascular event... | |||||||||||||
Medical condition: Peripheral artery disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) AT (Completed) ES (Completed) HU (Completed) GB (Completed) FR (Completed) PT (Completed) SE (Completed) BE (Completed) BG (Completed) DK (Completed) DE (Completed) NL (Completed) PL (Completed) SK (Completed) LT (Completed) LV (Completed) RO (Completed) EE (Completed) FI (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006778-11 | Sponsor Protocol Number: BQ123AMI12/06 | Start Date*: 2007-04-26 | |||||||||||
Sponsor Name:Medical University of Vienna, Department of Internal Medicine II | |||||||||||||
Full Title: ENDOTHELIN RECEPTOR BLOCKADE IN ACUTE ST-ELEVATION MYOCARDIAL INFARCTION | |||||||||||||
Medical condition: Acute myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001354-42 | Sponsor Protocol Number: IAMI-2014 | Start Date*: 2014-12-16 | |||||||||||
Sponsor Name:Örebro University Hospital | |||||||||||||
Full Title: Influenza vaccination After Myocardial Infarction (IAMI trial). A multicenter, prospective, randomized controlled clinical trial based on national angiography and angioplasty registries | |||||||||||||
Medical condition: Myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DK (Completed) LV (Completed) CZ (Completed) NO (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002210-12 | Sponsor Protocol Number: COMPLETE-2013-05-01 | Start Date*: 2014-12-17 |
Sponsor Name:Population Health Research Institute | ||
Full Title: A randomized, comparative effectiveness study of complete versus culprit-only revascularization strategies to treat multi-vessel disease after primary percutaneous coronary intervention for ST-segm... | ||
Medical condition: Effectiveness study of complete versus culprit-only revascularization strategies to treat multi vessel disease after primary PCI for STEMI | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-005499-20 | Sponsor Protocol Number: RM21 | Start Date*: 2022-07-05 |
Sponsor Name:Research Maatschap Cardiologen Rotterdam Zuid | ||
Full Title: COMPARE STEMI ONE- Comparison Of reduced DAPT followed by P2Y12 inhibitor Monotherapy with Prasugrel vs stAndard Regimen in STEMI patients treated with OCT-guided vs aNgio-guided completE revascul... | ||
Medical condition: ST elevated myocard infarction followed by PCI | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001398-97 | Sponsor Protocol Number: 20110118 | Start Date*: 2012-10-17 | ||||||||||||||||
Sponsor Name:Amgen Inc | ||||||||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab (AMG 145) is Used in Co... | ||||||||||||||||||
Medical condition: Dyslipidemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) SK (Completed) PL (Completed) GR (Completed) LT (Completed) BE (Completed) IT (Completed) NL (Completed) DK (Completed) AT (Completed) HU (Completed) PT (Completed) ES (Completed) CZ (Completed) EE (Completed) IS (Completed) GB (Completed) DE (Completed) BG (Completed) SE (Completed) LV (Completed) IE (Completed) NO (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004748-27 | Sponsor Protocol Number: EPIDAURUS-2020 | Start Date*: 2022-04-21 | |||||||||||
Sponsor Name:LMU University Hospital Munich | |||||||||||||
Full Title: Escalated single platelet inhibition for one month plus direct oral anticoagulation in patients with atrial fibrillation and acute coronary syndrome undergoing percutaneous coronary intervention | |||||||||||||
Medical condition: Patients with atrial fibrillation and ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) (biomarker -positive acute coronary syndrome) und... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002931-95 | Sponsor Protocol Number: LCC2010.01 | Start Date*: 2008-01-30 | |||||||||||
Sponsor Name:UZ Leuven | |||||||||||||
Full Title: The Effects of Nitric Oxide for Inhalation on Myocardial Infarction Size. | |||||||||||||
Medical condition: Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Prematurely Ended) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005272-19 | Sponsor Protocol Number: 20190184 | Start Date*: 2023-01-08 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction | |||||||||||||
Medical condition: Dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005933-34 | Sponsor Protocol Number: SFHI01 | Start Date*: 2021-08-09 | |||||||||||
Sponsor Name:Sorin CRM SAS (Microport CRM) | |||||||||||||
Full Title: Evaluation of a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in Acute Myocardial Infarction Patients treated with complete revascularization strategy | |||||||||||||
Medical condition: Patients with clinically stable, low to moderate complexity acute Myocardial Infarction (MI; troponine-positive Non-ST-Elevation MI or ST-Elevation MI) requiring primary Percutaneous Coronary Inte... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) NL (Ongoing) ES (Ongoing) IT (Ongoing) PT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022153-42 | Sponsor Protocol Number: ADVANCE | Start Date*: 2011-01-10 | |||||||||||
Sponsor Name:Cytori Therapeutics, Inc | |||||||||||||
Full Title: A phase II trial of safety and efficacy of ADRCs delivered via the intracoronary route in the treatment of patients with ST-elevation acute myocardial infarction – The ADVANCE Trial | |||||||||||||
Medical condition: patients with ST-elevation myocardial infarction after PCI with stent | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002557-29 | Sponsor Protocol Number: SK_DMDPA-03 | Start Date*: 2021-10-25 | |||||||||||
Sponsor Name:Synektik Spółka Akcyjna | |||||||||||||
Full Title: A Phase III Study of [11C]-DMDPA Tracer for Positron Emission Tomography PET-CT Myocardial Perfusion Imaging (MPI). | |||||||||||||
Medical condition: Known or suspected acute coronary syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001448-33 | Sponsor Protocol Number: SELECT-AMI | Start Date*: 2011-06-28 | |||||||||||
Sponsor Name:Cardiovascular Centre Aalst [...] | |||||||||||||
Full Title: A multi-centre, double-blind, randomised, placebo-controlled trial using CD133 enriched bone marrow cells following primary angioplasty for acute myocardial infarction with central core laboratory ... | |||||||||||||
Medical condition: Patients with acute ST-elevated myocardial infarction treated with primary percutaneous coronary intervention | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) BE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002868-17 | Sponsor Protocol Number: 633765 | Start Date*: 2016-05-06 | |||||||||||
Sponsor Name:Fundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC) | |||||||||||||
Full Title: Secondary Prevention of Cardiovascular Disease in the Elderly | |||||||||||||
Medical condition: Secondary Prevention of Major Cardiovascular Events (cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization) in post MI cohort. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Ongoing) CZ (Completed) HU (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003903-23 | Sponsor Protocol Number: P150946J | Start Date*: 2018-03-02 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Assessment of Beta blocker interruption after uncomplicated mYocardial infarction on Safety and Symptomatic cardiac events requiring hospitalization: The ABYSS Study | |||||||||||||
Medical condition: Myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000061-21 | Sponsor Protocol Number: I1V-MC-EIAN | Start Date*: 2012-10-25 | ||||||||||||||||||||||||||
Sponsor Name:Eli Lilly and Company | ||||||||||||||||||||||||||||
Full Title: Protocol I1V-MC-EIAN Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High-Risk for Vascular Outcomes - the ACCELERATE Study | ||||||||||||||||||||||||||||
Medical condition: High Risk Vascular Disease (HRVD) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) SK (Prematurely Ended) EE (Prematurely Ended) DE (Prematurely Ended) BE (Prematurely Ended) SE (Prematurely Ended) HU (Prematurely Ended) AT (Completed) ES (Prematurely Ended) LT (Prematurely Ended) DK (Prematurely Ended) IT (Prematurely Ended) CZ (Prematurely Ended) PL (Prematurely Ended) BG (Prematurely Ended) NL (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-014343-36 | Sponsor Protocol Number: GE IDE NO. I01209 | Start Date*: 2009-09-09 | |||||||||||
Sponsor Name:Deutsches Herzzentrum | |||||||||||||
Full Title: RANDOMIZED TRIAL OF PRASUGREL PLUS BIVALIRUDIN VERSUS CLOPIDOGREL PLUS HEPARIN IN PATIENTS WITH ACUTE STEMI BAVARIAN REPERFUSION ALTERNATIVES EVALUATION [BRAVE-4] TRIAL | |||||||||||||
Medical condition: Acute myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004565-14 | Sponsor Protocol Number: 20170625 | Start Date*: 2019-09-13 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardia... | |||||||||||||
Medical condition: Dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) NL (Trial now transitioned) GB (GB - no longer in EU/EEA) SE (Trial now transitioned) HU (Trial now transitioned) DK (Trial now transitioned) DE (Trial now transitioned) PL (Trial now transitioned) BG (Trial now transitioned) ES (Ongoing) PT (Trial now transitioned) FI (Trial now transitioned) AT (Trial now transitioned) LT (Trial now transitioned) LV (Trial now transitioned) EE (Ongoing) SK (Trial now transitioned) GR (Trial now transitioned) IT (Trial now transitioned) RO (Trial now transitioned) IS (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005435-98 | Sponsor Protocol Number: version_2.0_dated_19.04.2011 | Start Date*: 2012-06-21 | |||||||||||
Sponsor Name:Śląski Uniwersytet Medyczny w Katowicach | |||||||||||||
Full Title: A randomized, prospective, double-blind study with placebo to evaluate the efficacy of treatment of patients with angina resistant to pharmacological treatment and induced myocardial ischemia with... | |||||||||||||
Medical condition: Stable angina pectoris CCS II-IV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010869-23 | Sponsor Protocol Number: THIRST 02/2009 | Start Date*: 2009-06-22 | ||||||||||||||||||||||||||
Sponsor Name:OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO/CNR | ||||||||||||||||||||||||||||
Full Title: Acute and long term effects of thyroid hormone replacement therapy in patients with ST-Elevation Myocardial Infarction (STEMI) and borderline/reduced triiodothyronine levels. | ||||||||||||||||||||||||||||
Medical condition: All patients enrolled in the study should be in good clinical conditions, being ST-elevation myocardial infarction the main pathology,, without evidence of clinical/hemodynamic instability. All pat... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
